Earlier this year, we announced the new brand for our sterilization services, STERIS Applied Sterilization Technologies (AST). We are now excited to announce that, effective February 15, 2017, the new brand for our laboratory offering is STERIS Laboratories.
DetailsWe’re happy to publish the Application Note concerning the research carried out by our team at the Pharmaceutical Testing Laboratory in Utrecht, in conjunction with colleagues at the STERIS Gamma Sterilisation site in Ede, NL and the Bruker research lab in Bremen, on irradiated Oxybutynine
DetailsThe recent combination of STERIS Corporation and Synergy Health has created a leading global service supplier, providing Customers with a network of over 50 contract sterilization and laboratory facilities worldwide. As a combined organization, STERIS Applied Sterilization Technologies (AST) is committed to providing both global and local Customers with processing capacity through various technologies worldwide.
DetailsOn Tuesday 8th March Synergy Health, now part of STERIS team celebrated the opening of their brand new microbiological laboratory in Radeberg, Germany. This adds to the current network of STERIS Pharmaceutical Laboratories in the UK, Ireland, Netherlands, Italy and Czech Republic.
DetailsSignificant progress has been made to the warehouse extension project at our AST facility in Radeberg, Germany and we are very pleased to announce that it was completed at the end of 2015. The expansion project began in 2014 and will provide over 750 additional storage spaces for the Gamma and E-beam irradiation facility.
DetailsSTERIS plc (NYSE: STE) (“STERIS”) announced today that it has completed the previously announced combination of STERIS Corporation and Synergy Health plc (“Synergy”). As a result of the transaction, STERIS Corporation and Synergy are now combined under STERIS.
Details
